Home · Compare
James F. Polewaczyk vs Mayukh Sukhatme
💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Mayukh Sukhatme earned $250.5M (19089%) more than James F. Polewaczyk in their most recent fiscal years on record.
CompanyIDEXX LaboratoriesRoivant Sciences
TitlePresidentPresident and Chief Investment Officer
IndustryHealthcareHealthcare
Fiscal YearFY2023FY2024
Total Pay$1.3M$251.9M
Base Salary$559,154$550,000
Stock Awards—$170.2M
Bonus—$81.1M
Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy